--- title: "Human Normal Intravenous Immunoglobulin Evidence Reviews" ocid: "ocds-b5fd17-e69aa34a-9a64-4934-b7b4-350560ccfadd" canonical_url: "https://d3tenders.com/contract/?ocid=ocds-b5fd17-e69aa34a-9a64-4934-b7b4-350560ccfadd" markdown_url: "https://d3tenders.com/contract/ocds-b5fd17-e69aa34a-9a64-4934-b7b4-350560ccfadd.md" json_url: "https://d3tenders.com/contract/ocds-b5fd17-e69aa34a-9a64-4934-b7b4-350560ccfadd.json" source: "Contracts Finder" current_stage: "Tender" buyer: "NHS COMMISSIONING BOARD" published: "2017-12-22" --- # Human Normal Intravenous Immunoglobulin Evidence Reviews Buyer: NHS COMMISSIONING BOARD Current stage: Tender OCID: ocds-b5fd17-e69aa34a-9a64-4934-b7b4-350560ccfadd [View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-b5fd17-e69aa34a-9a64-4934-b7b4-350560ccfadd) [Download OCDS JSON](https://d3tenders.com/contract/ocds-b5fd17-e69aa34a-9a64-4934-b7b4-350560ccfadd.json) ## Summary The NHS Commissioning Board is currently in the tender stage of the procurement process for the project titled "Human Normal Intravenous Immunoglobulin Evidence Reviews," with an estimated value of £130,000. This initiative falls under the industry category of general management consultancy services, specifically aimed at supporting the Blood and Infection Programme of Care. The tender period is set to conclude on 12th January 2018, and the contract is expected to commence on 2nd March 2018, lasting until 31st March 2018. Interested parties must express their interest via email by the specified deadline and ensure registration on Bravo Solutions to access the tender documents. This tender presents a significant opportunity for businesses specialising in clinical evidence reviews, particularly those experienced in conducting systematic reviews related to immunoglobulin and other healthcare consultancy services. It is tailored for small and medium-sized enterprises (SMEs) that possess the capability to deliver evidence-based assessments and have strong analytical skills. Companies engaged in evaluation consultancy services or those with expertise in health-related research will likely find this tender particularly suited to their offerings, encouraging them to participate in a competitive process that could enhance their visibility and contract portfolio within the healthcare sector. ## Notice The Blood and Infection Programme of Care is seeking support for it Immunoglobulin Improving Value Project. Immunoglobulin is commissioned by NHS England in line with Department of Health Clinical guidelines for immunoglobulin use. https://www.gov.uk/government/publications/clinical-guidelines-for-immunoglobulin-use-second-edition-update The guidelines state which conditions immunoglobulin is recommended for and these are colour coded according to priority. A red classification indicates the highest priority as there could be a risk to life without treatment. A blue classification is for those indications where there is some evidence of benefit but for which there may be alternative treatments and for which treatment may be modified in times of supply shortages of immunoglobulin. Grey indications are those for which the evidence is weak, including rare disorders. It is envisaged that the successful organisation will be able to provide the required clinical evidence reviews to meet our objectives of providing safe, effective, evidence based care and will have the relevant experience, knowledge and capability to carry out detailed clinical evidence reviews for the grey indications from the Clinical Guidelines for Immunoglobulin Use 2nd edition. It is expected the chosen provider will be able to carry out the following: Scoping reviews to identify literature reporting on the use of immunoglobulin, in people with a grey indication. It would include a scoping of the literature to: 1. Identifying the research question (PICO) 2. Identifying relevant studies (search) 3. Study selection 4. Charting data 5. Collating, summarising and reporting results, interpretation and conclusions Then provide rapid reviews for those indications where there are experimental controlled trials or observational studies with a control group including: 1. Assessing quality of included literature 2. Measures of treatment effect 3. Summarising and interpreting results Please note that that this contract may be extended for an additional 3 months. Interested parties must be registered on Bravo Solutions in order to access the ITT documents. Please use the following address if you are not already registered: https://nhsengland.bravosolution.co.uk/web/login.html. IN ADDITION, PLEASE ENSURE YOU EMAIL VANESSA.AMISSAH@NHS.NET TO EXPRESS AN INTEREST BY FRIDAY 12TH JANUARY 2018, 12 NOON, AT THE LATEST. IT IS ENVISAGED THAT THE INVITATION TO TENDER DOCUMENTS WILL BE MADE AVAILABLE BY MID-LATE JANUARY 2018. ## Key Details | Field | Value | | --- | --- | | Publication source | Contracts Finder | | Latest notice | https://www.contractsfinder.service.gov.uk/Notice/f1a2a6b4-2233-43c8-bb15-b2667cbadc09 | | Notice type | Tender Notice | | Procurement type | Standard | | Procurement category | Services | | Procurement method | Limited | | Procurement method details | Competitive quotation (below threshold) | | Tender suitability | SME | | Awardee scale | Not specified | | All stages | Tender | ## Dates | Field | Value | | --- | --- | | Publication date | 22 Dec 2017 | | Submission deadline | 12 Jan 2018 | | Future notice date | Not specified | | Award date | Not specified | | Contract period | 2 Mar 2018 - 31 Mar 2018 | | Recurrence | Not specified | ## Values | Field | Value | | --- | --- | | Tender value | £130,000 | | Lots value | Not specified | | Awards value | Not specified | | Contracts value | Not specified | ## Status | Field | Value | | --- | --- | | Tender status | Active | | Lots status | Not specified | | Awards status | Not specified | | Contracts status | Not specified | ## Buyer | Field | Value | | --- | --- | | Main buyer | NHS COMMISSIONING BOARD | | Locality | LONDON | | Post town | North West London | | Postcode | NW1 2PL | | Country | England | | ITL 1 | TLI London | | ITL 2 | TLI3 Inner London - West | | ITL 3 | TLI36 Camden | | Local authority | Camden | | Electoral ward | Regent's Park | | Westminster constituency | Holborn and St Pancras | | Delivery location | TLI London | ## CPV Codes ### Divisions - 79 - Business services: law, marketing, consulting, recruitment, printing and security ### Codes - 79411000 - General management consultancy services - 79419000 - Evaluation consultancy services ## Release History - 22 Dec 2017 at 16:01 - Tender - Tender Notice - https://www.contractsfinder.service.gov.uk/Notice/f1a2a6b4-2233-43c8-bb15-b2667cbadc09 ## Documents - https://www.contractsfinder.service.gov.uk/Notice/f1a2a6b4-2233-43c8-bb15-b2667cbadc09 22nd December 2017 - Opportunity notice on Contracts Finder ## Notice URLs - https://nhsengland.bravosolution.co.uk/web/login.html - https://www.gov.uk/government/publications/clinical-guidelines-for-immunoglobulin-use-second-edition-update ## Provenance This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-b5fd17-e69aa34a-9a64-4934-b7b4-350560ccfadd. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-b5fd17-e69aa34a-9a64-4934-b7b4-350560ccfadd.json.